Anqi Li

1.2k total citations
64 papers, 724 citations indexed

About

Anqi Li is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Anqi Li has authored 64 papers receiving a total of 724 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Oncology, 21 papers in Molecular Biology and 11 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Anqi Li's work include Alzheimer's disease research and treatments (8 papers), Cancer Cells and Metastasis (7 papers) and Dementia and Cognitive Impairment Research (6 papers). Anqi Li is often cited by papers focused on Alzheimer's disease research and treatments (8 papers), Cancer Cells and Metastasis (7 papers) and Dementia and Cognitive Impairment Research (6 papers). Anqi Li collaborates with scholars based in China, Australia and United States. Anqi Li's co-authors include Wentao Yang, Shuling Zhou, Rui Bi, Ming Li, Yan Xu, Tengfei Guo, Mengwen Zhang, Qian Xiao, Noelle R. Jurcak and Zihai Li and has published in prestigious journals such as Neurology, Annals of Neurology and Scientific Reports.

In The Last Decade

Anqi Li

58 papers receiving 716 citations

Peers

Anqi Li

ONCOL

PRM

IMMUN

Lingyun Sun China

Mark Ross United Kingdom

Anna Konstorum United States

Jeffrey Douaiher United States

Rong Yu China

Fábio Pereira Spain

Francisco Bautista Spain

Mariya Farooqui United States

Min Cheol Lee South Korea

Lingyun Sun China

Anqi Li

150 ×0.6

ONCOL

232 ×1.1

106 ×0.7

PRM

74 ×0.7

84 ×0.8

IMMUN

Citations per year, relative to Anqi Li Anqi Li (= 1×) peers Lingyun Sun

Countries citing papers authored by Anqi Li

Since Specialization

Citations

This map shows the geographic impact of Anqi Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anqi Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anqi Li more than expected).

Fields of papers citing papers by Anqi Li

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anqi Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anqi Li. The network helps show where Anqi Li may publish in the future.

Co-authorship network of co-authors of Anqi Li

This figure shows the co-authorship network connecting the top 25 collaborators of Anqi Li. A scholar is included among the top collaborators of Anqi Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anqi Li. Anqi Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Li, Anqi, et al.. (2025). Understanding the complexity of tumor-associated macrophages: Druggable and therapeutic insights. Acta Pharmaceutica Sinica B. 15(9). 4456–4475. 1 indexed citations

Wu, Yuankai, Huizhi Zhang, Yang Liu, et al.. (2025). Comprehensive Analysis of 15 Cases of ELOC-RCC and Identification of Novel Mutation Site. The American Journal of Surgical Pathology. 49(12). 1288–1306. 1 indexed citations

Wu, Bill X., Hakan Çam, Chelsea Bolyard, et al.. (2025). Targeting TGFβ docking receptor glycoprotein A repetitions predominant (GARP) via novel chimeric antigen receptor (CAR)-T cell platform to treat glioblastoma. Neuro-Oncology. 27(12). 3087–3103. 1 indexed citations

Zhu, Linyu, et al.. (2024). IFN-γ-responsiveness of lymphatic endothelial cells inhibits melanoma lymphatic dissemination via AMPK-mediated metabolic control. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1870(7). 167314–167314. 1 indexed citations

Wang, Zheng, Anqi Li, Yujie Lu, et al.. (2024). Association of tumor immune infiltration and prognosis with homologous recombination repair genes mutations in early triple-negative breast cancer. Frontiers in Immunology. 15. 1407837–1407837. 2 indexed citations

Zhang, Kun, et al.. (2024). Plasma genome-wide mendelian randomization identifies potentially causal genes in idiopathic pulmonary fibrosis. Respiratory Research. 25(1). 379–379. 2 indexed citations

Han, Inkyu, et al.. (2024). Evaluating Occupational Workforce and Practices in New York Metropolitan Nail Salons. NEW SOLUTIONS A Journal of Environmental and Occupational Health Policy. 34(4). 268–277. 1 indexed citations

Wang, Zheng, Yujie Lu, Anqi Li, et al.. (2024). Association between homologous recombination deficiency status and carboplatin treatment response in early triple-negative breast cancer. Breast Cancer Research and Treatment. 208(2). 429–440. 2 indexed citations

Deng, Siyu, Anqi Li, & Yubo Zhang. (2023). Discovery of the new alpha-glucosidase inhibitor with therapeutic potential in type 2 diabetes mellitus by a novel high-throughput virtual screening and free energy evaluation. Journal of Molecular Graphics and Modelling. 121. 108447–108447. 4 indexed citations

10.

Kong, Hui, Qianming Bai, Anqi Li, Xiaoyan Zhou, & Wentao Yang. (2022). Characteristics of HER2-negative breast cancers with FISH-equivocal status according to 2018 ASCO/CAP guideline. Diagnostic Pathology. 17(1). 5–5. 8 indexed citations

11.

Li, Anqi, Gina D. Kusuma, Dominic Wall, et al.. (2021). Advances in automated cell washing and concentration. Cytotherapy. 23(9). 774–786. 35 indexed citations

12.

He, Haoqiang, Hui Zhang, Kun Qin, et al.. (2020). A randomized controlled trial for gualou danshen granules in the treatment of unstable angina pectoris patients with phlegm-blood stasis syndrome. Medicine. 99(33). e21593–e21593. 5 indexed citations

13.

Yue, Dongli, Xiaojuan Shi, Shasha Liu, et al.. (2020). Chloroquine Inhibits Stemness of Esophageal Squamous Cell Carcinoma Cells Through Targeting CXCR4-STAT3 Pathway. Frontiers in Oncology. 10. 311–311. 11 indexed citations

14.

Wu, Weibin, Cunlong Zhang, Zijian Liu, et al.. (2020). Discovery of triazolo [1,5-a] pyridine derivatives as novel JAK1/2 inhibitors. Bioorganic & Medicinal Chemistry Letters. 30(14). 127225–127225. 3 indexed citations

15.

Zuo, Li, Wei Niu, & Anqi Li. (2019). Isolation of Circulating Tumor Cells of Ovarian Cancer by Transferrin Immunolipid Magnetic Spheres and Its Preliminary Clinical Application. Nano LIFE. 9(01n02). 1940001–1940001. 3 indexed citations

16.

Li, Anqi, Ian FitzPatrick, Siow Teng Chan, et al.. (2019). Automated Counterflow Centrifugal System for Small-Scale Cell Processing. Journal of Visualized Experiments. 6 indexed citations

17.

Xu, Yan, Rui Bi, Xiaoyu Tu, et al.. (2017). Low frequency of BRAF and KRAS mutations in Chinese patients with low-grade serous carcinoma of the ovary. Diagnostic Pathology. 12(1). 87–87. 9 indexed citations

18.

Ba, Yue, Huang Huang, Catherine C. Lerro, et al.. (2016). Occupation and Thyroid Cancer. Journal of Occupational and Environmental Medicine. 58(3). 299–305. 29 indexed citations

19.

Liu, Dandan, Dan Qiao, Meijuan Wang, et al.. (2014). [Expressions of TERT during the development of rat liver cancer under the interventions of oxymatrine and selenium enriched yeast].. PubMed. 30(2). 171–3. 1 indexed citations

20.

Shui, Ruohong, Anqi Li, Fei Yang, et al.. (2014). Primary squamous cell carcinoma of the breast with unusual basal-HER2 phenotype.. PubMed. 7(8). 5203–9. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact